Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Public Will Have Access To "Real-Time" Recall Data

This article was originally published in The Silver Sheet

Executive Summary

MEDICAL DEVICE RECALLS REACH A NEW HIGH IN 2002 at 585, a 10% rise over the previous benchmark set in 2001. Nearly 75% of 2002 recall actions placed in Class II. The upward trend in recalls comes as FDA prepares to launch a new, Internet-based recall system. With the "Recall Enterprise System," the agency aims to provide "real-time" information via the web on corrections and removals actions. The new system is expected to challenge the ability of both manufacturers and FDA to efficiently evaluate and process recall data. [A tabulation of device recalls from 2002 is included]

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT036075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel